| Sorafenib studied in …STUDIED_INderived200 of 443show all (up to 200) |
|---|
| → studied in | NCT07836530Phase 3 · not yet recruiting Study Comparing BGB-B2033 With Sorafenib or Lenvatinib in Relapsed Hepatocellular Carcinoma · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma,Malignant Liver Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03533582Phase 3 · active not recruiting Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery · 443 trials list this drug (32 active) | — | — | Hepatoblastoma,Hepatocellular Malignant Neoplasm, Not Otherwise Specified,Childhood Hepatocellular Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02559778Phase 2 · recruiting Pediatric Precision Laboratory Advanced Neuroblastoma Therapy · 443 trials list this drug (32 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07787429Phase 2 · recruiting Evaluation of the Safety and Efficacy of Mifamurtide Versus Standard Treatment With Sorafenib in Patients With High-risk Osteosarcoma · 443 trials list this drug (32 active) | — | — | Osteosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04039607Phase 3 · completed A Study of Nivolumab in Combination With Ipilimumab in Participants With Advanced Hepatocellular Carcinoma · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04770896Phase 3 · active not recruiting A Study of Atezolizumab With Lenvatinib or Sorafenib Versus Lenvatinib or Sorafenib Alone in Hepatocellular Carcinoma Previously Treated With Atezolizumab and Bevacizumab · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01946529Phase 2 · completed Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell Tumors · 443 trials list this drug (32 active) | — | — | Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,Desmoplastic Small Round Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02029001Phase 2 · recruiting Adapting Treatment to the Tumor Molecular Alterations for Patients With Advanced Solid Tumors: MyOwnSpecificTreatment · 443 trials list this drug (32 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03298451Phase 3 · active not recruiting Study of Durvalumab and Tremelimumab as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05117957Phase 2 · completed Efficacy and Safety of Sorafenib in Previously Treated Advanced Hepatocellular Carcinoma: SOPT Study · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01171651Phase 2 · completed A Study of Pexa-Vec (JX-594) Prior to Sorafenib to Treat Unresectable Primary Hepatocellular Carcinoma · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05669339Phase 2 · recruiting AD HOC Trial: Artificial Intelligence-Based Drug Dosing In Hepatocellular Carcinoma · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04723004Phase 3 · completed Evaluate the Safety and Efficacy of Toripalimab Combined With Bevacizumab Versus Sorafenib Therapy for HCC · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02185560active not recruiting Prospective, Non-interventional, Post-authorization Safety Study That Includes All Patients Diagnosed as Unresectable Differentiated Thyroid Carcinoma and Treated With Sorafenib · 443 trials list this drug (32 active) | — | — | Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01871766Phase 2 · active not recruiting Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy · 443 trials list this drug (32 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00494182Phase 2 · active not recruiting Sorafenib in Combination With Carboplatin and Paclitaxel in Treating Participants With Metastatic or Recurrent Head and Neck Squamous Cell Cancer · 443 trials list this drug (32 active) | — | — | Head and Neck Squamous Cell Carcinoma,Laryngeal Squamous Cell Carcinoma,Oral Cavity Squamous Cell Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03247088Phase 1/Phase 2 · active not recruiting Sorafenib, Busulfan and Fludarabine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia Undergoing Donor Stem Cell Transplant · 443 trials list this drug (32 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02562755Phase 3 · completed Hepatocellular Carcinoma Study Comparing Vaccinia Virus Based Immunotherapy Plus Sorafenib vs Sorafenib Alone · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05468359Phase 1/Phase 2 · recruiting Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients · 443 trials list this drug (32 active) | — | — | Solid Neoplasm,Childhood Malignant Neoplasm,Childhood Solid Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03017326Phase 3 · active not recruiting Paediatric Hepatic International Tumour Trial · 443 trials list this drug (32 active) | — | — | Hepatoblastoma,Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01840592Phase 2 · active not recruiting Sorafenib Plus Doxorubicin in Patients With Advanced Hepatocellular Carcinoma With Disease Progression on Sorafenib · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03164057Phase 2 · active not recruiting A Trial of Epigenetic Priming in Patients With Newly Diagnosed Acute Myeloid Leukemia · 443 trials list this drug (32 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01187199Phase 1 · active not recruiting Phase I Trial of Bevacizumab and Temsirolimus in Combination With 1) Carboplatin, 2) Paclitaxel, 3) Sorafenib for the Treatment of Advanced Cancer · 443 trials list this drug (32 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03132454Phase 1 · active not recruiting Palbociclib and Sorafenib, Decitabine, or Dexamethasone in Treating Patients With Recurrent or Refractory Leukemia · 443 trials list this drug (32 active) | — | — | Acute Lymphoblastic Leukemia,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05068752Phase 2 · completed Phase II Trial of Vemurafenib and Sorafenib in Pancreatic Cancer · 443 trials list this drug (32 active) | — | — | Pancreatic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02298348Phase 1 · active not recruiting Sorafenib and Cyclophosphamide/Topotecan in Patients With Relapsed and Refractory Neuroblastoma · 443 trials list this drug (32 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07463651Phase 3 · recruiting MRD-guided Maintenance Post-HCT: Gilteritini vs Sorafenib · 443 trials list this drug (32 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04720716Phase 3 · completed A Study to Compare the Effectiveness and Safety of IBI310 Combined With Sintilimab Versus Sorafenib in the First-line Treatment of Advanced HCC · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02143726Phase 2 · active not recruiting Sorafenib Tosylate With or Without Everolimus in Treating Patients With Advanced, Radioactive Iodine Refractory Hurthle Cell Thyroid Cancer · 443 trials list this drug (32 active) | — | — | Thyroid Gland Oncocytic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01903694Phase 3 · completed Randomized Trial Sorafenib-Pravastatin Versus Sorafenib Alone for the Palliative Treatment of Child-Pugh A Hepatocellular Carcinoma · 443 trials list this drug (32 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01730937Phase 3 · completed Sorafenib Tosylate With or Without Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer · 443 trials list this drug (32 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01658878Phase 1/Phase 2 · completed An Immuno-therapy Study to Evaluate the Effectiveness, Safety and Tolerability of Nivolumab or Nivolumab in Combination With Other Agents in Patients With Advanced Liver Cancer · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03755791Phase 3 · active not recruiting Study of Cabozantinib in Combination With Atezolizumab Versus Sorafenib in Participants With Advanced Hepatocellular Carcinoma (HCC) Who Have Not Received Previous Systemic Anticancer Therapy · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07264010Phase 2/Phase 3 · not yet recruiting Sorafenib Combined With Venetoclax as Pre-emptive Therapy Strategy for MRD+ AML: a Prospective, Single-arm, Multicenter Clinical Study · 443 trials list this drug (32 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05033522Phase 2/Phase 3 · suspended Immunotherapy for Advanced Liver Cancer · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03412773Phase 3 · completed A Study of Tislelizumab Versus Sorafenib in Participants With Unresectable Hepatocellular Carcinoma (HCC) · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03037437Phase 2 · completed Sorafenib Induced Autophagy Using Hydroxychloroquine in Hepatocellular Cancer · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05822752Phase 2 · active not recruiting Study to Evaluate Adverse Events, and Change in Disease Activity, When Intravenously (IV) Infused With Livmoniplimab in Combination With IV Infused Budigalimab in Adult Participants With Hepatocellular Carcinoma (HCC) · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06474663Phase 1 · withdrawn A Phase I Study Investigating the Combination of Cladribine, Low Dose Cytarabine and Sorafenib Alternating With Decitabine in Pediatric Relapsed and Refractory Acute Leukemias · 443 trials list this drug (32 active) | — | — | Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01754987Phase 1/Phase 2 · completed A Study of Vitamin C in the Treatment of Liver Cancer to Determine if it is Safe and Effective · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma,Malignant Liver Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00639262Phase 1 · completed Combination of Sorafenib and Radiation for Brain Metastases and Primary Brain Tumors · 443 trials list this drug (32 active) | — | — | Brain Neoplasm,Primary Brain Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05713994recruiting Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular Carcinoma · 443 trials list this drug (32 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03899428Phase 2 · recruiting Immune Checkpoint Therapy vs Target Therapy in Reducing Serum HBsAg Levels in Patients With HBsAg+ Advanced Stage HCC · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02716012Phase 1 · unknown First-in-Human Safety, Tolerability and Antitumour Activity Study of MTL-CEBPA in Patients With Advanced Liver Cancer · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma,Malignant Liver Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04710641Phase 2 · completed Radomised Phase II Study of MTL-CEBPA Plus Sorafenib or Sorafenib Alone · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04709380Phase 3 · terminated Phase III RCT of Radiotherapy Plus Toripalimab Versus Sorafenib in Advanced Hepatocellular Carcinoma With PVTT · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04344158Phase 3 · active not recruiting A Phase III Clinical Trial of AK105 Injection Combined With Anlotinib Hydrochloride Capsules Versus Sorafenib in Subjects With Advanced Hepatocellular Carcinoma (HCC) · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02576509Phase 3 · completed An Investigational Immuno-therapy Study of Nivolumab Compared to Sorafenib as a First Treatment in Patients With Advanced Hepatocellular Carcinoma · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03439891Phase 2 · completed Sorafenib and Nivolumab in Treating Participants With Unresectable, Locally Advanced or Metastatic Liver Cancer · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06482086Phase 2 · recruiting Efficacy of Organoid-Based Drug Screening to Guide Treatment for Locally Advanced Thyroid Cancer · 443 trials list this drug (32 active) | — | — | Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03009461Phase 2 · completed Sorafenib Plus Hepatic Arterial Infusion Versus Sorafenib for HCC with Major Portal Vein Tumor Thrombosis · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02143401Phase 1 · completed Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors · 443 trials list this drug (32 active) | — | — | Malignant Neoplasm,Solid Neoplasm,Malignant Solid Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06690697Phase 2 · recruiting Combination of Toripalimab and JS004 Therapy for ccRCC · 443 trials list this drug (32 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03606590Phase 2 · completed Effect of Tumor Treating Fields (TTFields, 150kHz) Concomitant with Sorafenib for Advanced Hepatocellular Carcinoma (HCC) (HEPANOVA) · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05594095Phase 2 · recruiting SNF Platform Study of HR+/ HER2-advanced Breast Cancer · 443 trials list this drug (32 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01906216Phase 3 · completed Sorafenib Chemoembolization Evaluation Controlled Trial · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06221683Phase 2 · recruiting Clinical Study of Induction Therapy Options Based on Molecular Subtyping and MRD in Children and Adolescents With AML · 443 trials list this drug (32 active) | — | — | Acute Myeloid Leukemia,Childhood Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06532084Phase 2 · recruiting Sorafenib Relapase Prophylaxis After HCT With PTBCy Regimen · 443 trials list this drug (32 active) | — | — | Myelodysplastic Syndrome,Myeloproliferative Neoplasm,Acute Myeloid Leukemia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06527495Phase 1/Phase 2 · unknown Clinical Pharmacogenetic Study of Sorafenib in Egyptian Patients With Hepatocellular Carcinoma · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02856126Phase 3 · completed HAIC Plus Sorafenib Versus TACE Plus Sorafenibfor Advanced HCC · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04763408completed A Study to Evaluate the Safety and Tolerability of Lenvatinib in Participants With Advanced or Unresectable Hepatocellular Carcinoma · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05717738unknown Combined TACE, TKI/Anti-VEGF and ICIs as Conversion Therapy for Advanced Hepatocellular Carcinoma · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01578109Phase 1 · completed Sorafenib Tosylate Before and After Donor Bone Marrow Transplant in Treating Patients With Acute Myeloid Leukemia · 443 trials list this drug (32 active) | — | — | Acute Myeloid Leukemia with FLT3/ITD Mutation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02135874Phase 2 · completed Clofarabine, Idarubicin, Cytarabine, Vincristine Sulfate, and Dexamethasone in Treating Patients With Newly Diagnosed or Relapsed Mixed Phenotype Acute Leukemia · 443 trials list this drug (32 active) | — | — | Acute Leukemia of Ambiguous Lineage,Acute Undifferentiated Leukemia,Mixed Phenotype Acute Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06030895NA · completed Sorafenib In Egyptian Patients With Hepatocellular Carcinoma. · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03878524Phase 1 · terminated Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial · 443 trials list this drug (32 active) | — | — | Hematopoietic and Lymphatic System Neoplasm,Hematopoietic and Lymphoid Cell Neoplasm,Malignant Solid Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03764293Phase 3 · completed A Study to Evaluate SHR-1210 in Combination With Apatinib as First-Line Therapy in Patients With Advanced HCC · 443 trials list this drug (32 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04560894Phase 2/Phase 3 · unknown SCT-I10A Plus SCT510 Versus Sorafenib as First-Line Therapy for Advanced Hepatocellular Carcinoma · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06177496unknown Influence of Sarcopenia in Hepatocellular Carcinoma Patients · 443 trials list this drug (32 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00606866Phase 3 · completed MRI Study of BAY 43-9006 in Metastatic Renal Cell Carcinoma · 443 trials list this drug (32 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02279719Phase 1/Phase 2 · completed A Study of BBI608 in Combination With Sorafenib, or BBI503 in Combination With Sorafenib in Adult Patients With Hepatocellular Carcinoma · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00634634Phase 1/Phase 2 · completed Phase I/II Trial of Letrozole and Sorafenib in Post-Menopausal Hormone-Receptor + Breast Cancer · 443 trials list this drug (32 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05594147completed An Observational Study, Called ROCURS, to Learn About COVID-19 Related Outcomes in People With Cancer Who Are Treated With Tyrosine Kinase Inhibitors (TKIs) Including Regorafenib or Sorafenib · 443 trials list this drug (32 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00496756Phase 2 · terminated Sorafenib in Treating Patients With Metastatic or Unresectable Kidney Cancer · 443 trials list this drug (32 active) | — | — | Malignant Kidney Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03434379Phase 3 · completed A Study of Atezolizumab in Combination With Bevacizumab Compared With Sorafenib in Patients With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01703455Phase 2 · completed Activity of Sorafenib in Salivary Gland Cancer · 443 trials list this drug (32 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04135690Phase 2 · unknown HAIC Plus Toripalimab vs. HAIC Plus Sorafenib for HCC With PVTT: a Non-comparative, Prospective, Randomized Trial · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05313958Phase 2/Phase 3 · unknown Treateament of Newly Diagnosed Acute Monocytic Leukemia in Children · 443 trials list this drug (32 active) | — | — | Leukemia,Childhood Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02627963Phase 3 · completed A Study to Compare Tivozanib Hydrochloride to Sorafenib in Participants With Refractory Advanced Renal Cell Carcinoma (RCC) · 443 trials list this drug (32 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03722498Phase 2 · withdrawn Phase Ⅱ Study of HAIC of FOLFOX vs. Sorafenib in HCC Refractory to TACE · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02728050Phase 1/Phase 2 · completed Filgrastim, Cladribine, Cytarabine, and Mitoxantrone With Sorafenib in Treating Patients With Newly-Diagnosed, Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome · 443 trials list this drug (32 active) | — | — | Myelodysplastic Syndrome,Myeloproliferative Neoplasm,Acute Myeloid Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00064350Phase 2 · completed Sorafenib in Treating Patients With Refractory Non-Small Cell Lung Cancer · 443 trials list this drug (32 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00813293Phase 2 · completed Sorafenib Therapy Prior to Radiofrequency Ablation for Intermediate Sized Hepatocellular Cancer · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02303444completed An Observational Study in Differentiated Thyroid Cancer Which is Radioactive Iodine (RAI) Refractory to Assess the Use of Multikinase Inhibitors · 443 trials list this drug (32 active) | — | — | Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05889949unknown Microvascular Invasion for Guiding Treatment of Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04387695Phase 3 · unknown SBRT+TACE+Sorafenib Vs Sorafenib in the Treatment of uHCC With PVTT · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04992143Phase 2 · unknown TACE+Tilelizumab+Sorafenib in the Treatment of BCLC Stage C HCC · 443 trials list this drug (32 active) | — | — | BCLC Stage C Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03236649Phase 3 · terminated The Phase III Study of Icaritin Versus Sorafenib in PD-L1 Positive Advanced Hepatocellular Carcinoma Subjects · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03582618Phase 2 · terminated CVM-1118 and Sorafenib Combination in Subjects With Advanced Hepatocellular Carcinoma · 443 trials list this drug (32 active) | — | — | Malignant Neoplasm,Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05601895unknown The Gut Microbiome in FLT3- AL Undergoing Allo-HSCT With Or Without Sorafenib Maintenance · 443 trials list this drug (32 active) | — | — | Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05596968unknown The Gut Microbiome and Sorafenib Maintenance Therapy in FLT3-ITD Positive AML After Allo-HSCT · 443 trials list this drug (32 active) | — | — | Acute Myeloid Leukemia with FLT3/ITD Mutation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05596981unknown The Gut Microbiome in FLT3-ITD+ AML Undergoing Allo-HSCT With Or Without Sorafenib Maintenance After Allo-HSCT · 443 trials list this drug (32 active) | — | — | Acute Myeloid Leukemia with FLT3/ITD Mutation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02349867Phase 1 · completed Neoadjuvant Chemotherapy Followed by Radiation Therapy and Gemcitabine/Sorafenib/Vorinostat in Pancreatic Cancer · 443 trials list this drug (32 active) | — | — | Malignant Pancreatic Neoplasm,Pancreatic Carcinoma,Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00625378Phase 3 · completed Sorafenib Long Term Extension Program · 443 trials list this drug (32 active) | — | — | Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04985136Phase 3 · terminated A Study of Camrelizumab Combined With Rivoceranib Mesylate Versus Investigator's Choice of Regimen in Treatment of Patients With Advanced Hepatocellular Carcinoma (HCC) · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01988493Phase 1/Phase 2 · completed Efficacy, Safety, and Pharmacokinetic of MSC2156119J in Asian Participants With Hepatocellular Carcinoma · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02575339Phase 1/Phase 2 · terminated MLN0128 Compared to Sorafenib in Advanced or Metastatic Hepatocellular Carcinoma · 443 trials list this drug (32 active) | — | — | Liver Neoplasm,Hepatocellular Carcinoma,Malignant Liver Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04326439Phase 2 · terminated AflacLL1901 (CHOA-AML) · 443 trials list this drug (32 active) | — | — | Acute Myeloid Leukemia,Childhood Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00392821Phase 1/Phase 2 · completed Dosing and Effectiveness Study of Sorafenib and RAD001 in the Treatment of Patients With Advanced Kidney Cancer · 443 trials list this drug (32 active) | — | — | Malignant Kidney Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05404516Phase 2 · unknown Combination of Sorafenib With Standard Therapy in Newly Diagnosed Adult CBF AML · 443 trials list this drug (32 active) | — | — | Core Binding Factor Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01434602Phase 1/Phase 2 · completed Phase I-II Everolimus and Sorafenib in Recurrent High-Grade Gliomas · 443 trials list this drug (32 active) | — | — | Glioblastoma,Brain Neoplasm,WHO Grade 3 Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04788420completed Influence of Co-existing Mutations on Sorafenib Maintenance Therapy After Allo-HSCT for Patients With FLT3-ITD AML · 443 trials list this drug (32 active) | — | — | Acute Myeloid Leukemia,Acute Myeloid Leukemia with FLT3/ITD Mutation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00920816Phase 3 · completed Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer · 443 trials list this drug (32 active) | — | — | Kidney Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04465734Phase 3 · withdrawn A Clinical Study to Compare the Efficacy and Safety of HLX10 in Combination With HLX04 Versus Sorafenib as the First-line Treatment in Patients With Locally Advanced or Metastatic HCC · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02794337Phase 2/Phase 3 · unknown TACE vs TACE+SBRT for Unresectable Hepatocellular Cancer · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02354898Phase 1 · completed A Study of BBI503 in Advanced Solid Tumors, or BBI503/ Sorafenib in Advanced Hepatocellular Carcinoma · 443 trials list this drug (32 active) | — | — | Solid Neoplasm,Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02358395Phase 1 · completed A Study of BBI608 Administrated With Sorafenib in Adult Patients With Advanced Hepatocellular Carcinoma · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01761266Phase 3 · completed A Multicenter, Open-Label, Phase 3 Trial to Compare the Efficacy and Safety of Lenvatinib (E7080) Versus Sorafenib in First-line Treatment of Participants With Unresectable Hepatocellular Carcinoma · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01724606Phase 1 · completed Whole Brain Radiotherapy (WBRT) With Sorafenib for Breast Cancer Brain Metastases (BCBM) · 443 trials list this drug (32 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02178358Phase 2 · completed A Study of LY2157299 in Participants With Advanced Hepatocellular Carcinoma · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05113290Phase 4 · unknown Effect and Safety of Recombinant Human Adenovirus Type 5 in Advanced HCC With Stable Disease After Sorafenib Treatment · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01248247Phase 2 · completed BATTLE-2 Program: A Biomarker-Integrated Targeted Therapy Study in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer · 443 trials list this drug (32 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01900002Phase 2 · completed Sorafenib Tosylate and Yttrium Y 90 Glass Microspheres in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma,Adult Hepatocellular Carcinoma,BCLC Stage C Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05121571NA · completed The Efficacy and Safety of HAIC With FOLFOX vs Sorafenib for Patients Who Showed TACE-resistant: a Retrospective Study · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00844883Phase 2 · completed Study of Sorafenib and Transarterial Chemoembolization (TACE) to Treat Hepatocellular Carcinoma · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04674345Phase 2/Phase 3 · unknown Sorafenib Maintenance for Prophylaxis of Leukemia Relapse in Allo-HSCT Recipients With FLT3 Negative Acute Leukemia · 443 trials list this drug (32 active) | — | — | Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01620216Phase 2 · terminated Targeted Therapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia · 443 trials list this drug (32 active) | — | — | Acute Lymphoblastic Leukemia,Acute Myeloid Leukemia,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01263951Phase 2 · unknown Study of Everolimus and Sorafenib in Patients With Advanced Thyroid Cancer Who Progressed on Sorafenib Alone · 443 trials list this drug (32 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01141478NA · terminated Proton Radiotherapy Plus Sorafenib Versus Sorafenib for Patients With HCC Exceeding San Francisco Criteria · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00892658Phase 1 · completed Sorafenib-RT in Treating Hepatocellular Carcinoma (SHEP) · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01444807Phase 2 · unknown Evaluate the Efficacy of Sorafenib in Renal Cell Carcinoma Patients After a Radical Resection of the Metastases · 443 trials list this drug (32 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04127396Phase 4 · unknown Lenvatinib Plus TACE Versus Sorafenib Plus TACE for HCC With PVTT · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03630120Phase 2 · terminated Adaptive Tyrosine Kinase Inhibitor (TKI) Therapy In Patients With Thyroid Cancer · 443 trials list this drug (32 active) | — | — | Thyroid Gland Follicular Carcinoma,Malignant Thyroid Gland Neoplasm,Thyroid Gland Medullary Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04926532Phase 1/Phase 2 · unknown Toripalimab Plus Sorafenib in Patients With Advanced-Stage Hepatocellular Carcinoma · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02292173Phase 1 · completed Trametinib in Combination With Sorafenib in Patients With Advanced Hepatocellular Cancer · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma,Malignant Liver Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01271504Phase 1/Phase 2 · completed E7050 in Combination With Sorafenib Versus Sorafenib Alone as First Line Therapy in Participants With Hepatocellular Carcinoma · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02973204completed Circulating Tumor Cells and Tumor DNA in HCC and NET · 443 trials list this drug (32 active) | — | — | Neuroendocrine Tumor,Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01887717Phase 3 · terminated Efficacy Evaluation of TheraSphere to Treat Inoperable Liver Cancer With Blockage of the Portal Vein · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01636908NA · completed Determination of Intratumoral Concentrations of Kinase Inhibitors in Patients With Advanced Solid Malignancies. · 443 trials list this drug (32 active) | — | — | Malignant Neoplasm,Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03971201Phase 2 · unknown A Randomized Phase II Trial of Surgery Plus Sorafenib vs. Sorafenib Alone for Hepatocellular Cancer (HCC) With Portal Vein Invasion · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01033240Phase 2 · completed CS1008- in Combination With Sorafenib Compared to Sorafenib Alone in Subjects With Advanced Liver Cancer · 443 trials list this drug (32 active) | — | — | Liver Neoplasm,Hepatocellular Carcinoma,Malignant Liver Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01915602Phase 2 · completed Refametinib in Combination With Sorafenib in RAS Mutant Hepatocellular Carcinoma (HCC) · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03563170Phase 1/Phase 2 · withdrawn QUILT-3.072: NANT Hepatocellular Carcinoma (HCC) Vaccine · 443 trials list this drug (32 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02129322Phase 2 · withdrawn Effect of Adjuvant Therapy by Sorafenib, Oxaliplatin and S-1 · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02460991Phase 3 · terminated A Study of ONCO-DOX in Locally Advanced Hepatocellular Carcinoma · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01197170Phase 1 · completed Hormone Receptor Positive Disease Across Solid Tumor Types: A Phase I Study of Single-Agent Hormone Blockade and Combination Approaches With Targeted Agents to Provide Synergy and Overcome Resistance · 443 trials list this drug (32 active) | — | — | Malignant Neoplasm,Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03794440Phase 2/Phase 3 · unknown A Study to Evaluate the Efficacy and Safety of Sintilimab in Combination With IBI305 (Anti-VEGF Monoclonal Antibody) Compared to Sorafenib as the First-Line Treatment for Advanced Hepatocellular Carcinoma. · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01246986Phase 2 · completed A Study of LY2157299 in Participants With Hepatocellular Carcinoma · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01714609Phase 2 · completed The Effect of Sorafenib on Portal Pressure · 443 trials list this drug (32 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02988440Phase 1 · completed Study of Safety and Tolerability of PDR001 in Combination With Sorafenib and to Identify the Maximum Tolerated Dose and/or Phase 2 Dose for This Combination in Advanced Hepatocellular Patients · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01687673Phase 2 · completed Phase II Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00436215Phase 2 · completed Sorafenib and Bevacizumab to Treat Ovarian, Fallopian and Peritoneal Cancer · 443 trials list this drug (32 active) | — | — | Fallopian Tube Neoplasm,Ovarian Neoplasm,Malignant Fallopian Tube Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03645980Phase 1/Phase 2 · unknown DKN-01 Inhibition in Advanced Liver Cancer · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01076010Phase 3 · completed An Extension Treatment Protocol for Subjects Who Have Participated in a Study of Tivozanib Versus Sorafenib in Kidney Carcinoma (Protocol AV-951-09-301). · 443 trials list this drug (32 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04553458completed Factors Affecting Post-treatment Outcomes in Patients With Hepatocellular Carcinoma · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00892424Phase 1/Phase 2 · completed Sorafenib-RT Treatment for Liver Metastasis (SLIM) · 443 trials list this drug (32 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03644511terminated Use of Sorafenib and/or Regorafenib in Liver Cancer (Hepatocellular Carcinoma) Subsequent to Another Systemic First-line Treatment · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01561833Phase 1 · completed A Pilot Study of Sorafenib Examining Biomarkers in Refractory or Relapsed T-Cell Lymphoma Patients · 443 trials list this drug (32 active) | — | — | T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00880542Phase 2 · terminated Sorafenib and Ifosfamide in Treating Patients With High-Grade Soft Tissue Sarcoma or Bone Sarcoma That Can Be Removed by Surgery · 443 trials list this drug (32 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02560779Phase 1/Phase 2 · completed Trial of TRC105 and Sorafenib in Patients With HCC · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00543504Phase 1 · completed Bevacizumab in Multiple Phase I Combinations · 443 trials list this drug (32 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02989870Phase 1 · withdrawn Sorafenib and Bavituximab Plus SBRT in Unresectable Hepatocellular Carcinoma · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma,Malignant Liver Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01775501Phase 2 · completed Sorafenib + mFOLFOX for Hepatocellular Carcinoma · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02716766Phase 2 · completed Study of SECOX Versus Sorafenib as First-Line Treatment in Patients With Advanced Hepatocellular Carcinoma (HCC) · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03578874Phase 2 · completed SECOX as Neoadjuvant Therapy in Patients With Locally Advanced HCC · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02530476Phase 1/Phase 2 · completed Phase I/II, Study of Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) + Sorafenib in Acute Myeloid Leukemia · 443 trials list this drug (32 active) | — | — | Leukemia,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03170895Phase 2 · completed Combination of Sorafenib and Omacetaxine Mepesuccinate in Newly Diagnosed or Relapsed/Refractory AML Carrying FLT3-ITD · 443 trials list this drug (32 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03622541Phase 2 · completed Using Sorafenib as a Salvage Treatment for Relapsed or Refractory Acute Myeloid Leukemia Carrying FLT3-ITD · 443 trials list this drug (32 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04143191Phase 3 · unknown Sorafenib Plus TACE Versus Sorafenib Alone as Postoperative Adjuvant Treatment for Resectable Primary Advanced HCC · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02638428Phase 2 · unknown Genomics-Based Target Therapy for Children With Relapsed or Refractory Malignancy · 443 trials list this drug (32 active) | — | — | Childhood Solid Neoplasm,Childhood Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02406521Phase 1 · completed Exploratory Study of Radium-223 and VEGF-Targeted Therapy in Patients With Metastatic Renal Cell Carcinoma and Bone Mets · 443 trials list this drug (32 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02867280Phase 3 · terminated Sorafenib Treatment in Patients With Hepatocellular Carcinoma With Microvascular Invasion After Radical Resection · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02240433Phase 1 · completed A Study of LY2157299 in Participants With Unresectable Hepatocellular Cancer (HCC) · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02504983Phase 4 · unknown Clinical Trial for GALNT14 Genotype - Guided, Sorafenib in Combination With TACE in Hepatocellular Carcinoma · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02196857Phase 2 · completed Sorafenib Plus 5-Azacitidine Initial Therapy of Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MS) With FLT3-ITD Mutation · 443 trials list this drug (32 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02436902Phase 3 · unknown Adjuvant Therapies for Patients With HCC and MVI · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02645981Phase 2/Phase 3 · completed Efficacy and Safety of Donafenib in Patients With Advanced Hepatocellular Carcinoma · 443 trials list this drug (32 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02691780NA · withdrawn Study to Evaluate the Safety and Efficacy of Sorafenib, in Subject With Refractory Solid Tumors · 443 trials list this drug (32 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00095459Phase 1 · completed BAY 43-9006 (Sorafenib) and Bevacizumab (Avastin) To Treat Solid Tumors · 443 trials list this drug (32 active) | — | — | Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00287495Phase 1 · terminated BAY 43-9006 (Sorafenib) to Treat Patients With Kaposi's Sarcoma · 443 trials list this drug (32 active) | — | — | Kaposi Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02774187Phase 3 · completed Sorafenib Alone Versus Sorafenib Combined With HAIC for Advanced HCC · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00634751Phase 1/Phase 2 · completed CO07204-Phase I/II of Oxaliplatin, Capecitabine & Sorafenib for Advanced Pancreatic & Biliary Carcinoma · 443 trials list this drug (32 active) | — | — | Bile Duct Neoplasm,Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00654238Phase 2 · completed Phase II Trial of Sorafenib (Nexavar) in Patients With Advanced Thyroid Cancer · 443 trials list this drug (32 active) | — | — | Thyroid Gland Anaplastic Carcinoma,Thyroid Gland Medullary Carcinoma,Poorly Differentiated Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00954278Phase 1 · completed Intra-patient Dose Escalation Study of Sorafenib in Advanced Non-small Cell Lung Cancer · 443 trials list this drug (32 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04163237Phase 3 · unknown Combined Immunotherapy and Targeted Therapy for Advanced Liver Cancer · 443 trials list this drug (32 active) | — | — | Malignant Liver Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02084732Phase 2 · completed Safety and Efficacy of Sorafenib in Patients With Advanced Thyroid Cancer: a Phase II Clinical Study · 443 trials list this drug (32 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02288507Phase 1 · withdrawn Sorafenib Concurrent With Yttrium-90 Transarterial Radioembolization in Patients With Advanced Hepatocellular Cancer · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04152356unknown Combined Immunotherapy and Targeted Therapy for Hepatocellular Carcinoma · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01030783Phase 3 · completed A Study to Compare Tivozanib (AV-951) to Sorafenib in Subjects With Advanced Renal Cell Carcinoma · 443 trials list this drug (32 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02961998Phase 4 · completed Preventive Effect of Celecoxib on Sorafenib-related Hand Foot Syndrome, a Single Center, Randomized Controlled Clinical Trail · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02747537Phase 2 · withdrawn Treating Relapsed/Recurrent/Refractory Pediatric Solid Tumors With Sorafenib in Combination With Irinotecan · 443 trials list this drug (32 active) | — | — | Childhood Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02474290Phase 2/Phase 3 · completed Sorafenib for Prophylaxis of Leukemia Relapse in Allo-HSCT Recipients With FLT3-ITD Positive AML · 443 trials list this drug (32 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00474929Phase 1/Phase 2 · completed Sorafenib and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma · 443 trials list this drug (32 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02733809Phase 4 · unknown Mechanism of Sorafenib Resistance in Patients With Advanced Hepatocellular Carcinoma · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02529761NA · unknown TACE With or Without Sorafenib in Intermediate Stage Hepatocellular Carcinoma · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01195649terminated Advanced Renal Cell Carcinoma, With Failure or Unsuitable on Prior Interferon-alpha or Interleukin-2 Based Therapy · 443 trials list this drug (32 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00901901Phase 3 · completed Nexavar-Tarceva Combination Therapy for First Line Treatment of Patients Diagnosed With Hepatocellular Carcinoma · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03780634Phase 2 · withdrawn HAIC Plus PD-1 Antibody vs HAIC Plus Sorafenib for Advanced HCC · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00727532NA · terminated Sorafenib in Treating Patients With Locally Advanced or Metastatic Kidney Cancer · 443 trials list this drug (32 active) | — | — | Malignant Kidney Neoplasm,Hereditary Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01844947Phase 1 · completed Phase I Study With Sorafenib in Addition to Vinflunine in Metastatic Transitional Cell Carcinoma of the Urothelial Tract · 443 trials list this drug (32 active) | — | — | Urothelial Carcinoma,Malignant Bladder Neoplasm,Malignant Ureter Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03812770Phase 2 · unknown Phase 2 Study of Sorafenib Plus HAIC of FOLFOX vs. Sorafenib Plus HAIC of OXA for Advanced HCC · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00754923Phase 2 · terminated Sorafenib in Treating Non-Smokers or Former Light Smokers With Relapsed or Refractory Stage IIIB or Stage IV Non-Small Cell Lung Cancer · 443 trials list this drug (32 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02425605Phase 2 · completed Efficacy of Localized Concurrent Chemo-radiation Therapy and Sorafenib Sequential Therapy in Advanced Hepatocellular Carcinoma · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00605566Phase 2 · completed Efficacy Study of Sorafenib and Cyclophosphamide to Treat Neuroendocrine Tumors · 443 trials list this drug (32 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01498952Phase 1 · completed MEDI-573 in Combination With SOC in Unresectable or Metastatic HCC. · 443 trials list this drug (32 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00610246Phase 1 · completed A Study of Radiation With Sorafenib in Advanced Cancer · 443 trials list this drug (32 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02748304NA · terminated Sorafenib Combined With Aspirin to Prevent the Recurrence in High-risk Patients With Hepatocellular Carcinoma · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02412475Phase 1 · terminated Epigenetic Reprogramming in Relapse AML · 443 trials list this drug (32 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01306058Phase 1/Phase 2 · completed Sorafenib and TRC105 in Hepatocellular Cancer · 443 trials list this drug (32 active) | — | — | Hepatocellular Adenoma,Liver Neoplasm,Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03812783Phase 2 · unknown HAIC of FOLFOX Plus Sorafenib vs HAIC of FOLFIRINOX Plus Sorafenib for Advcanced HCC · 443 trials list this drug (32 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |